CompletedNot applicableNCT00601146

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease

This research study is being done because patients with a history of chest radiation treatment for Hodgkin's disease have been shown to be at increased risk for developing lung cancer a number of years out from treatment. The risk appears to be further increased among patients with a smoking history. Currently, the practice is to recommend annual low-dose chest CT scans in survivors of Hodgkin's disease who have received prior chest radiation treatment and who have at least a moderate smoking history. In this study, the CT scans will be read and interpreted by the study radiologist, and the results recorded in a consistent manner.

Checked against the public recordLast updated Jan 21, 2020 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations2
SponsorDana-Farber Cancer Institute
01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
Dana-Farber Cancer Institute
Interventions being studied
Procedure: chest computed tomography scan
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * 5 years or longer from initial Hodgkin's disease diagnosis * Current age 18 or older * Received mediastinal irradiation and/or alkylating-agent based chemotherapy * Smoking history of 10-pack years or more, or current smoker * Pre-approval from the participant's insurance company for the CT study Exclusion Criteria: * Patients with a history of lung cancer * Currently receiving treatment for another cancer diagnosis * Known diagnosis of any metastatic cancer * Pregnant women

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Brigham and Women's HospitalBoston, Massachusetts
  • Dana-Farber Cancer InstituteBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 21, 2020. Always confirm current availability with the study team.

View original record ↗